Research
Print page Print page
Switch language
  1. The Capital Region of Denmark
  2. Researchers
  3. Svend Erik Nielsen
The Capital Region of Denmark - a part of Copenhagen University Hospital

Svend Erik Nielsen

Chief Consultant

Building: ,

Denmark

Latest publications View all (18) »

  1. Published

    Pre-treatment serum vitamin D deficiency is associated with increased inflammatory biomarkers and short overall survival in patients with pancreatic cancer

    Research output: Contribution to journal › Journal article › Research › peer-review

  2. Published

    Prognostic impact of Charlson's Age-Comorbidity Index and other risk factors in patients with pancreatic cancer

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Prognostic Value of Combined Detection of Serum IL6, YKL-40, and C-reactive Protein in Patients with Unresectable Pancreatic Cancer

    Research output: Contribution to journal › Journal article › Research › peer-review

Frequent journals View all »

  1. Annals of Oncology

    ISSNs: 0923-7534

    Additional searchable ISSN (Electronic): 1569-8041

    Oxford University Press, United Kingdom

    Journal

  2. Anticancer Research

    ISSNs: 0250-7005

    Additional searchable ISSN (Electronic): 1791-7530

    International Institute of Anticancer Research, Greece

    Journal

  3. PLOS ONE

    ISSNs: 1932-6203

    Additional searchable ISSN (Electronic): 1932-6203

    Public Library of Science, United States

    Indexed in DOAJ

    Journal

  4. Acta - Unio Internationalis Contra Cancrum

    ISSNs: 0020-7136, 1065-7541, 0365-3056

    Additional searchable ISSN (Electronic): 1097-0215

    John/Wiley & Sons, Inc. John/Wiley & Sons Ltd, United States

    Journal

  5. Oncology

    ISSNs: 0030-2414

    Additional searchable ISSN (Electronic): 1423-0232

    S./Karger AG, Switzerland

    Journal

View graph of relations

Expertises

GI cancer

Main research areas

Colorectal cancer

Current research

Sub-investigator in more phase III studies

Potential conflicts of interest

Advisory board member at Roche and Bayers

ID: 32212524